National ARVC Data Registry and Bio Bank

CompletedOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Arrhythmogenic Right Ventricular Cardiomyopathy
Trial Locations (16)

Unknown

Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary

BC Children's Hospital, Vancouver

University of British Columbia, St. Paul's Hospital, Vancouver

University of Victoria, Victoria Jubilee Hospital, Victoria

St. Boniface Hospital, Winnipeg

Queen Elizabeth II, Halifax Infirmary, Halifax

McMaster University, Faculty of Health Sciences, Hamilton

Lawson Health Research Institute, London

Ottawa Heart Institute, Ottawa

St. Michael's Hospital, Toronto

The Hospital for Sick Children, Toronto

Toronto General Hospital, Toronto

McGill University Health Centre, Montreal

Montreal Heart Institute, Montreal

St. Justine Hospital, Montreal

Institut Universitaire de Cardiologie, Université Laval, Québec

All Listed Sponsors
collaborator

Population Health Research Institute

OTHER

collaborator

Medtronic

INDUSTRY

collaborator

Boston Scientific Corporation

INDUSTRY

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

University of British Columbia

OTHER

NCT01804699 - National ARVC Data Registry and Bio Bank | Biotech Hunter | Biotech Hunter